- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Environmental Agenda
- Focus on Women's Health
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Christopher P. Kenny (Chris)
Event 24 results
Speaking Engagement
September 29, 2021
Chris Kenny to Speak at Virginia-DC HFMA Fall Education Conference
Webinar
May 20, 2021
Practical Steps to Prepare Your Hospital’s Controlled Substances Diversion Program for Government Scrutiny
Webinar
April 29, 2021
Protecting Your CARES Act Provider Relief Funds During Audit and Enforcement: The Time to Act Is Now
Webinar
November 10, 2020
13th Annual King & Spalding Medical Device Summit
Webinar
October 13, 2020
What You Need to Know About CMS’s Latest Rulemakings Affecting Hospital Medicare Reimbursement, Including IPPS, OPPS and the Part C Proposed Rule
Webinar
Webinar
April 24, 2020
Compliance Issues Related to Receipt of CARES Act Funding, plus Latest Congressional and CMS Actions Related to COVID-19
Webinar
March 27, 2020
Impact of Congressional Actions Related to COVID-19 on Healthcare Providers
Webinar
March 19, 2020
Impact of CMS’s Section 1135 Waiver on Hospital Operations and Reimbursement During the Coronavirus Pandemic
Webinar
January 22, 2020
A Review of the Practical and Legal Challenges Posed by CMS’s New Hospital Price Transparency Rule
Webinar
December 13, 2019
Direct-to-Employer Contracting by Healthcare Providers: Legal and Practical Considerations
Webinar
July 23, 2019
#Metoo Risks Facing Healthcare Providers